CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease

Virology

Volumn 361, Issue 1, 2007, Pages 34-44

  Boritz, Eli ^a   Rapaport, Eric L ^a   Campbell, Thomas B ^a   Koeppe, John R ^a   Wilson, Cara C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

CD4+ T cells; Epitopes; Gag protein; Human immunodeficiency virus type 1; Mutations

Indexed keywords

EPITOPE; NUCLEOTIDE;

AMINO ACID SEQUENCE; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DISEASE PROGRESSION; EPITOPES, T-LYMPHOCYTE; FLUORIDES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; METHACRYLATES; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYURETHANES; RNA, VIRAL; T-CELL ANTIGEN RECEPTOR SPECIFICITY; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34047271627     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.10.040     Document Type: Article

References (51)

1. + T cells during primary immune responses. Proc. Natl. Acad. Sci. U. S. A. 100 25 (2003) 15006-15010
2. Altfeld M., Addo M.M., Shankarappa R., Lee P.K., Allen T.M., Yu X.G., Rathod A., Harlow J., O'Sullivan K., Johnston M.N., Goulder P.J., Mullins J.I., Rosenberg E.S., Brander C., Korber B., and Walker B.D. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J. Virol. 77 13 (2003) 7330-7340
3. Barouch D.H., Kunstman J., Kuroda M.J., Schmitz J.E., Santra S., Peyerl F.W., Krivulka G.R., Beaudry K., Lifton M.A., Gorgone D.A., Montefiori D.C., Lewis M.G., Wolinsky S.M., and Letvin N.L. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415 6869 (2002) 335-339
4. Birk M., Vahlne A., Sonnerborg A., and Sallberg M. Nonsynonymous mutations within the human immunodeficiency virus type 1 p17 gene are clustered to sequences binding to the host human leukocyte antigen class I molecules. AIDS Res. Hum. Retroviruses 14 3 (1998) 241-248
5. + CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 169 11 (2002) 6376-6385
6. + T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels. J. Virol. 78 22 (2004) 12638-12646
7. + T cell immunity and viral escape following acute HIV-1 infection. J. Immunol. 171 7 (2003) 3837-3846
8. + T-cell-epitope escape mutant virus selected in vivo. Nat. Med. 7 7 (2001) 795-800
9. Coffin J.M. Genetic diversity and evolution of retroviruses. Curr. Top. Microbiol. Immunol. 176 (1992) 143-164
10. Delwart E.L., Pan H., Sheppard H.W., Wolpert D., Neumann A.U., Korber B., and Mullins J.I. Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J. Virol. 71 10 (1997) 7498-7508
11. + T cells. Nature 417 6884 (2002) 95-98
12. Felsenstein J. PHYLIP-phylogeny inference package. (Version 3.2). Cladistics 5 (1989) 164-166
13. + T cells. J. Immunol. 163 2 (1999) 650-658
14. Frost S.D., Wrin T., Smith D.M., Kosakovsky Pond S.L., Liu Y., Paxinos E., Chappey C., Galovich J., Beauchaine J., Petropoulos C.J., Little S.J., and Richman D.D. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. U. S. A. 102 51 (2005) 18514-18519
15. Fuller M.J., and Zajac A.J. Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 170 1 (2003) 477-486
16. Goulder P.J., Phillips R.E., Colbert R.A., McAdam S., Ogg G., Nowak M.A., Giangrande P., Luzzi G., Morgan B., Edwards A., McMichael A.J., and Rowland-Jones S. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3 2 (1997) 212-217
17. Harari A., Rizzardi G.P., Ellefsen K., Ciuffreda D., Champagne P., Bart P.A., Kaufmann D., Telenti A., Sahli R., Tambussi G., Kaiser L., Lazzarin A., Perrin L., and Pantaleo G. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 100 4 (2002) 1381-1387
18. Harari A., Petitpierre S., Vallelian F., and Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103 3 (2004) 966-972
19. Harcourt G.C., Garrard S., Davenport M.P., Edwards A., and Phillips R.E. HIV-1 variation diminishes CD4 T lymphocyte recognition. J. Exp. Med. 188 10 (1998) 1785-1793
20. + T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 77 20 (2003) 10900-10909
21. Jamieson B.D., Yang O.O., Hultin L., Hausner M.A., Hultin P., Matud J., Kunstman K., Killian S., Altman J., Kommander K., Korber B., Giorgi J., and Wolinsky S. Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses. J. Immunol. 171 10 (2003) 5372-5379
22. Kaufmann D.E., Bailey P.M., Sidney J., Wagner B., Norris P.J., Johnston M.N., Cosimi L.A., Addo M.M., Lichterfeld M., Altfeld M., Frahm N., Brander C., Sette A., Walker B.D., and Rosenberg E.S. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 78 9 (2004) 4463-4477
23. Kelleher A.D., Long C., Holmes E.C., Allen R.L., Wilson J., Conlon C., Workman C., Shaunak S., Olson K., Goulder P., Brander C., Ogg G., Sullivan J.S., Dyer W., Jones I., McMichael A.J., Rowland-Jones S., and Phillips R.E. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193 3 (2001) 375-386
24. + T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia. J. Acquired Immune Defic. Syndr. 41 2 (2006) 140-148
25. Korber B. HIV signature and sequence variation analysis. In: Rodrigo A.G., and Learn G.H. (Eds). Computational Analysis of HIV Molecular Sequences (2001), Kluwer Academic Publishers, Dordrecht, Netherlands 55-72
26. Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., Tang Y., Holmes E.C., Allen T., Prado J.G., Altfeld M., Brander C., Dixon C., Ramduth D., Jeena P., Thomas S.A., St John A., Roach T.A., Kupfer B., Luzzi G., Edwards A., Taylor G., Lyall H., Tudor-Williams G., Novelli V., Martinez-Picado J., Kiepiela P., Walker B.D., and Goulder P.J. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10 3 (2004) 282-289
27. + T cells. J. Exp. Med. 200 6 (2004) 701-712
28. Liu S.L., Schacker T., Musey L., Shriner D., McElrath M.J., Corey L., and Mullins J.I. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J. Virol. 71 6 (1997) 4284-4295
29. Malhotra U., Holte S., Dutta S., Berrey M.M., Delpit E., Koelle D.M., Sette A., Corey L., and McElrath M.J. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J. Clin. Invest. 107 4 (2001) 505-517
30. Malhotra U., Holte S., Zhu T., Delpit E., Huntsberry C., Sette A., Shankarappa R., Maenza J., Corey L., and McElrath M.J. Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection. J. Virol. 77 4 (2003) 2663-2674
31. Martinez-Picado J., Prado J.G., Fry E.E., Pfafferott K., Leslie A., Chetty S., Thobakgale C., Honeybourne I., Crawford H., Matthews P., Pillay T., Rousseau C., Mullins J.I., Brander C., Walker B.D., Stuart D.I., Kiepiela P., and Goulder P.J. Fitness cost of escape mutations in p24 gag in association with control of human immunodeficiency virus type 1. J. Virol. 80 7 (2006) 3617-3623
32. + T cells by primary HIV-1 infection: potential mechanism of vaccine failure. AIDS Res. Hum. Retroviruses 13 3 (1997) 205-210
33. McNeil A.C., Shupert W.L., Iyasere C.A., Hallahan C.W., Mican J.A., Davey Jr. R.T., and Connors M. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 98 24 (2001) 13878-13883
34. + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3 11 (2002) 1061-1068
35. Nei M., and Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3 5 (1986) 418-426
36. + T cells. AIDS Res. Hum. Retroviruses 20 3 (2004) 315-325
37. Oxenius A., Price D.A., Dawson S.J., Gunthard H.F., Fischer M., Perrin L., Ramirez E., Fagard C., Hirschel B., Scullard G., Weber J.N., McLean A.R., Phillips R.E., and Swiss H.I.V.c.s. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load. AIDS 16 17 (2002) 2317-2322
38. Palmer B.E., Boritz E., Blyveis N., and Wilson C.C. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1- specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J. Virol. 76 12 (2002) 5925-5936
39. + T cell maturation and function. J. Immunol. 172 5 (2004) 3337-3347
40. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5 5 (1999) 518-525
41. +, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J. Virol. 72 1 (1998) 876-881
42. + T lymphocyte turnover and activation increase upon viral rebound. J. Clin. Invest. 115 2 (2005) 443-450
43. Seth N., Kaufmann D., Lahey T., Rosenberg E.S., and Wucherpfennig K.W. Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. J. Immunol. 175 10 (2005) 6948-6958
44. Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., Huang X.L., and Mullins J.I. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73 12 (1999) 10489-10502
45. Soudeyns H., Paolucci S., Chappey C., Daucher M.B., Graziosi C., Vaccarezza M., Cohen O.J., Fauci A.S., and Pantaleo G. Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope. Eur. J. Immunol. 29 11 (1999) 3629-3635
46. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., Kubo R.T., Chesnut R.W., Grey H.M., and Sette A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160 7 (1998) 3363-3373
47. Wang F.X., Kimura T., Nishihara K., Yoshimura K., Koito A., and Matsushita S. Emergence of autologous neutralization-resistant variants from preexisting human immunodeficiency virus (HIV) quasi species during virus rebound in HIV type 1-infected patients undergoing highly active antiretroviral therapy. J. Infect. Dis. 185 5 (2002) 608-617
48. Wilson C.C., Brown R.C., Korber B.T., Wilkes B.M., Ruhl D.J., Sakamoto D., Kunstman K., Luzuriaga K., Hanson I.C., Widmayer S.M., Wiznia A., Clapp S., Ammann A.J., Koup R.A., Wolinsky S.M., and Walker B.D. Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the Ariel Project for the prevention of transmission of HIV from mother to infant. J. Virol. 73 5 (1999) 3975-3985
49. + T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. J. Infect. Dis. 182 3 (2000) 792-798
50. Yang O.O., Sarkis P.T., Ali A., Harlow J.D., Brander C., Kalams S.A., and Walker B.D. Determinants of HIV-1 mutational escape from cytotoxic T lymphocytes. J. Exp. Med. 197 10 (2003) 1365-1375
51. + T cells endowed with proliferative capacity. J. Exp. Med. 198 12 (2003) 1909-1922